ANGLE plc

AGL

GB0034330679

Advanced Medical Equipment & Technology

Delayed London S.E. Other stock markets 04:13:36 2024-05-22 am EDT			5-day change	1st Jan Change
19.43 ^GBX	-5.23%		-16.44%	+65.35%

May. 16	Bens Creek considers administration; Nexxen inks deal	AN
May. 16	ANGLE plc Announces Publication of Study Using the Parsortix System	CI

ANGLE PLC Appoints Greg Shaw as Its Scientific Advisor

May 14, 2018 at 06:30 am EDT

ANGLE PLC appointed Greg Shaw as its scientific advisor. Currently, Shaw serves at University College Hospital as consultant urological surgeon.

Latest news about ANGLE plc

Bens Creek considers administration; Nexxen inks deal	May. 16	AN
ANGLE plc Announces Publication of Study Using the Parsortix System	May. 16	CI
Angle shares up on assay development deal with AstraZeneca	May. 03	AN
Angle shares up on assay development deal with AstraZenaca	May. 03	AN
Angle Plc to Supply Prostate Cancer Androgen Receptor Detection Assay to AstraZeneca	May. 03	MT
AIM WINNERS & LOSERS: Fletcher King optimistic; Angle in Astra deal	May. 03	AN
Confident start before US jobs data	May. 03	AN
InterContinental Hotels makes first-quarter progress	May. 03	AN
ANGLE plc Announces New Commercial Agreement with Large Pharma	May. 03	CI
No record close for FTSE 100; mixed trade in US	Apr. 24	AN
No record close for FTSE 100; mixed trade in US	Apr. 24	AN
Angle plc to Develop New Cancer Assay in Deal with AstraZeneca	Apr. 24	MT
Angle shares jump on supplier agreement with with AstraZeneca	Apr. 24	AN
AIM WINNERS & LOSERS: Filtronic jumps as lifts outlook	Apr. 24	AN
Angle PLC Announces New Commercial Agreement with AstraZeneca PLC	Apr. 24	CI
Angle granted patents in US and Europe for Cellkeep slide	Apr. 22	AN
Angle plc Secures European Patent for CellKeep Technology	Apr. 22	MT
ANGLE plc Presents Parsortix HER2 Assay at AACR Annual Meeting 2024	Apr. 08	CI
Transcript : ANGLE plc - Special Call	Feb. 05
Angle highlights supportive data for DNA analysis tool	Jan. 22	AN
Stocks up ahead of US nonfarm payrolls	Jan. 04	AN
Angle shares soar following "breakthrough" cancer diagnostics results	Jan. 04	AN
Retailers Next and JD Sports bookend FTSE 100	Jan. 04	AN
AIM WINNERS & LOSERS: Angle soars on clinical tests; Likewise sales up	Jan. 04	AN
Next leads buoyant FTSE 100 amid services PMIs	Jan. 04	AN

ANGLE plc is a United Kingdom-based liquid biopsy company with circulating tumor cell (CTC) solutions for use in research, drug development and clinical oncology using a simple blood sample. Its circulating tumor cell (CTC) harvesting technology known as the Parsortix PC1 System enables complete downstream analysis of the sample, including whole cell imaging and proteomic analysis and full genomic and transcriptomic molecular analysis. The Parsortix PC1 system is a medical device for the capture and harvest of intact CTCs from metastatic breast cancer (MBC) patient blood for user-validated analysis. Its commercial businesses focus on diagnostic products and clinical services. Its diagnostic products include the Parsortix system and associated consumables. Its services include custom made assay development and clinical trial testing for pharma. The Parsortix technology uses a microfluidic technology in the form of a single use cassette to capture and then harvest CTCs from whole blood.

Sector

Advanced Medical Equipment & Technology

Calendar

2024-06-25 - Annual General Meeting

More about the company

Income Statement Evolution

More financial data

Ratings for ANGLE plc

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

0.205 GBP

Average target price

0.685 GBP

Spread / Average Target

+234.15%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Medical Diagnostic & Testing Equipment

	1st Jan change	Capi.
ANGLE PLC	+65.35%	67.9M
SARTORIUS AG	-20.29%	18.19B
QUIDELORTHO CORPORATION	-43.89%	2.77B
INNER MONGOLIA FURUI MEDICAL SCIENCE CO., LTD.	+23.49%	1.96B
SHANGHAI MICROPORT EP MEDTECH CO., LTD.	-3.70%	1.61B
BIOTAGE AB	+31.11%	1.31B
SHANGHAI AOHUA PHOTOELECTRICITY ENDOSCOPE CO., LTD.	-16.85%	960M
CONTEC MEDICAL SYSTEMS CO.,LTD	-23.12%	881M
REVENIO GROUP OYJ	+5.45%	809M
CELLAVISION AB	+24.76%	590M

Medical Diagnostic & Testing Equipment

ANGLE plc

Equities

AGL

GB0034330679

Advanced Medical Equipment & Technology

ANGLE PLC Appoints Greg Shaw as Its Scientific Advisor

Latest news about ANGLE plc

Chart ANGLE plc

Company Profile

Income Statement Evolution

Ratings for ANGLE plc

Analysts' Consensus

EPS Revisions

Quarterly earnings - Rate of surprise

Sector Medical Diagnostic & Testing Equipment